EFFICACY AND SAFTY OF DAPAGLIFLOZIN FOR HEART FAILURE: A SYSTEMIC REVIEW

被引：0
|
作者：
Wang, Zhe [1 ]
机构：
[1] Tianjin Med Univ, Second Hosp, Blood Purificat, Tianjin, Peoples R China
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO723
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial
    Butt, Jawad H.
    Jhund, Pardeep S.
    Belohlavek, Jan
    de Boer, Rudolf A.
    Chiang, Chern-En
    Desai, Akshai S.
    Drozdz, Jaroslaw
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Katova, Tzvetana
    Kitakaze, Masafumi
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Langkilde, Anna Maria
    Lindholm, Daniel
    Bachus, Erasmus
    Martinez, Felipe
    Merkely, Bela
    Petersson, Magnus
    Saraiva, Jose F. Kerr
    Shah, Sanjiv J.
    Vaduganathan, Muthiah
    Vardeny, Orly
    Wilderang, Ulrica
    Claggett, Brian C.
    Solomon, Scott D.
    McMurray, John J., V
    CIRCULATION, 2022, 146 (16) : 1210 - 1224
  • [42] Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation
    Newland, D. M.
    Law, Y. M.
    Albers, E. L.
    Ali, R.
    Friedland-Little, J. M.
    Kemna, M. S.
    Knorr, L. R.
    Nemeth, T. L.
    Spencer, K. L.
    Hong, B. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S616 - S616
  • [43] Comparative Efficacy of Dapagliflozin and Empagliflozin of a Fixed Dose in Heart Failure: A Network Meta-Analysis
    Shi, Zepeng
    Gao, Feng
    Liu, Wei
    He, Xuezhi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [44] Dapagliflozin in Heart Failure and Acute Myocardial Infarction: A Systematic Review of the Association in Diabetic Patients
    Al-Tarawneh, Lina M.
    Al-Adwan, Abedallah J.
    Al-shaikhly, Faisal A.
    Almomani, Mazin M.
    Oduibat, Rahaf T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [45] How many of our heart failure patients would be eligible for dapagliflozin - A retrospective review
    Byrne, L.
    Wheen, P.
    O' Callaghan, D.
    Daly, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 111 - 111
  • [46] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [47] Early Clinical Experience with Dapagliflozin in Children with Heart Failure
    Newland, David M.
    Law, Yuk M.
    Albers, Erin L.
    Friedland-Little, Joshua M.
    Ahmed, Humera
    Kemna, Mariska S.
    Hong, Borah J.
    PEDIATRIC CARDIOLOGY, 2023, 44 (01) : 146 - 152
  • [48] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [49] Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure
    Modzelewski, Katherine L.
    Pipilas, Alexandra
    Bosch, Nicholas A.
    JAMA NETWORK OPEN, 2024, 7 (05) : E249305
  • [50] Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
    Myhre, Peder L.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Miao, Zi Michael
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    Desai, Akshay S.
    Lindholm, Daniel
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J. V.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2022, 10 (12) : 902 - 913
12345